Skip to content

Author

Michael L. Ferm

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

#small language model Preprint Oct 2026

Agentic LLM reasoning in pediatric diabetes outcome prediction from multimodal medical records

Using records from 2,489 youth with type 2 diabetes and 4,018 with type 1 diabetes, CEDAR (Clinical Evidence-Driven Agent for Risk-prediction), an evidence-citing, self-auditing LLM pipeline, outperformed trained machine learning in both cohorts.

Daniel Palacios, Guan-Tong Qi, Anna Kadi et al. · 0 citations
Sep 2026

Insulin Dose-Adjusted Hemoglobin A1c Has Suboptimal Performance for Identifying C-Peptide-Defined Partial Remission: The SEARCH for Diabetes in Youth Study.

OBJECTIVE Insulin dose-adjusted hemoglobin A1c (IDAA1c = HbA1c [%] + [4 × total daily dose in units/kg/day]) ≤9 is widely used to define partial remission in pediatric type 1 diabetes and as an eligibility criterion or outcome in disease-modifying therapy trials. However, it has not been validated in U.S. youth. Becaus...

Michael L. Ferm, Xiao-Fan Huang, Charles G. Minard et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.